Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the <scp>SilHF</scp> study): a randomized placebo‐controlled multicentre trial-Reference-Cited by-同舟云学术

Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo‐controlled multicentre trial

Published:2022-06-06 Issue:7 Volume:24 Page:1239-1248
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Cooper Trond J.¹,Cleland John G.F.²³,Guazzi Marco⁴,Pellicori Pierpaolo³⁵,Ben Gal Tuvia⁶,Amir Offer⁷,Al‐Mohammad Abdallah⁸,Clark Andrew L.⁵,McConnachie Alex³,Steine Kjetil⁹,Dickstein Kenneth¹⁰

Affiliation:

1. Stavanger University Hospital Stavanger Norway

2. National Heart Lung Institute, Imperial College London UK

3. Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit University of Glasgow, University Avenue Glasgow UK

4. Cardiology Department University of Milano, San Paolo Hospital Milan Italy

5. Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital Cottingham UK

6. Heart Failure Unit, Cardiology Department Rabin Medical Center, Petah Tikva and Sackler Faculty of Medicine, Tel Aviv University Tel Aviv Israel

7. Division of Cardiology, Hadassah Medical Center, Faculty of Medicine Hebrew University Jerusalem Israel & Azrieli Faculty of Medicine, Bar‐Ilan University Zfat Israel

8. University of Sheffield Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, the UK Sheffield UK

9. Department of Cardiology Akershus University Hospital Oslo Norway

10. University of Bergen, Stavanger University Hospital Stavanger Norway

Funder

Pfizer Foundation

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2527

Reference34 articles.